Amphetamine is bioequivalent to the reference listed drug product (RLD), Adderall XR extended-release capsules of Takeda Pharmaceuticals. This product will be manufactured at Granules manufacturing facility in Chantilly, Virginia, and is expected to be launched shortly, according to a company statement shared with stock exchanges.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/t8Qg40a
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Granules gets USFDA's nod for Amphetamine capsules
0 comments:
Post a Comment